Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
Kristine M. Erlandson(University of Colorado Denver), Steven Grinspoon(Massachusetts General Hospital), Sonya L. Heath(NorthShore University HealthSystem), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Alan Landay(The University of Texas Medical Branch at Galveston), Karen T. Tashima(Brown University), George A. Kuchel(UConn Health), Pamela S. Douglas(Duke University), Ariela R. Orkaby(Brigham and Women's Hospital), Michael T. Lu(Cancer Research And Biostatistics), Triin Umbleja(Harvard University), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Marissa R Diggs(Harvard University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Marcus Lacerda(Fundação de Medicina Tropical), Todd Brown(Johns Hopkins University), Markella V. Zanni(Harvard University)
Cited by 3
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k